158 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
AMN Healthcare (AMN) Expands Capabilities of ShiftWise Flex https://www.zacks.com/stock/news/2240143/amn-healthcare-amn-expands-capabilities-of-shiftwise-flex?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240143 Mar 13, 2024 - AMN Healthcare's (AMN) expansion of the capabilities of ShiftWise Flex is likely to enhance internal resource pool management for the healthcare system.
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution https://www.zacks.com/stock/news/2240028/pacbio-s-pacb-new-panel-to-aid-its-clinical-research-solution?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240028 Mar 13, 2024 - PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.
Integra LifeSciences (IART) Introduces MicroMatrix Flex https://www.zacks.com/stock/news/2239482/integra-lifesciences-iart-introduces-micromatrix-flex?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2239482 Mar 12, 2024 - Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
Philips (PHG) Aids Personal Health Business With New Campaign https://www.zacks.com/stock/news/2239363/philips-phg-aids-personal-health-business-with-new-campaign?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2239363 Mar 12, 2024 - Philips (PHG) launches #ShareTheCare brand positioning campaign for Philips Avent, bolstering the Personal Health segment.
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Up https://www.zacks.com/stock/news/2239362/orthofix-ofix-q4-earnings-beat-estimates-gross-margin-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2239362 Mar 12, 2024 - Orthofix's (OFIX) fourth-quarter earnings and revenues beat their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
Momentum Monday: Inflation Data in Focus this Week https://www.zacks.com/stock/news/2238816/momentum-monday-inflation-data-in-focus-this-week?cid=CS-ZC-FT-video_blog-2238816 Mar 11, 2024 - Want to start the week ahead of the pack? Check out Momentum Mondays
Thermo Fisher (TMO) Unveils CorEvitas Clinical Registry in GPP https://www.zacks.com/stock/news/2238707/thermo-fisher-tmo-unveils-corevitas-clinical-registry-in-gpp?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238707 Mar 11, 2024 - Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.
Here's Why You Should Retain Teleflex (TFX) Stock for Now https://www.zacks.com/stock/news/2238699/here-s-why-you-should-retain-teleflex-tfx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2238699 Mar 11, 2024 - Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
Medtronic's (MDT) MiniMed 780G System Study Data Favorable https://www.zacks.com/stock/news/2238698/medtronic-s-mdt-minimed-780g-system-study-data-favorable?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238698 Mar 11, 2024 - Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
Here's Why You Should Retain Walgreens Boots (WBA) For Now https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551 Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.

Pages: 1...5678910111213141516

<<<Page 10>